Candriam SCA’s ViewRay, Inc. VRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,812,970
Closed -$5.77M 896
2023
Q1
$5.77M Sell
1,812,970
-193,534
-10% -$819K 0.04% 336
2022
Q4
$8.99M Sell
2,006,504
-96,677
-5% -$421K 0.06% 294
2022
Q3
$7.66M Buy
2,103,181
+365,344
+21% +$1.23M 0.05% 318
2022
Q2
$4.94M Hold
1,737,837
0.04% 326
2022
Q1
$6.81M Sell
1,737,837
-112,042
-6% -$477K 0.05% 304
2021
Q4
$10.2M Buy
1,849,879
+609,987
+49% +$3.72M 0.07% 264
2021
Q3
$8.94M Hold
1,239,892
0.06% 295
2021
Q2
$8.18M Buy
1,239,892
+378,930
+44% +$2.02M 0.06% 313
2021
Q1
$3.16M Buy
860,962
+9
+0% +$44 0.03% 449
2020
Q4
$3.29M Sell
860,953
-20,752
-2% -$73.4K 0.03% 460
2020
Q3
$3.09M Sell
881,705
-33,899
-4% -$94.4K 0.03% 432
2020
Q2
$2.05M Buy
915,604
+291,802
+47% +$623K 0.02% 485
2020
Q1
$2.57M Buy
623,802
+119
+0% +$337 0.03% 490
2019
Q4
$2.63M Buy
623,683
+438,326
+236% +$1.42M 0.03% 504
2019
Q3
$538K Buy
185,357
+99,000
+115% +$587K 0.01% 679
2019
Q2
$757K Sell
86,357
-46,500
-35% -$378K 0.01% 695
2019
Q1
$982K Buy
132,857
+122,675
+1,205% +$946K 0.01% 637
2018
Q4
$62K Buy
+10,182
New +$76.3K ﹤0.01% 781

Other funds holding VRAY

Candriam SCA's VRAY Position: Q2 2023 in Review

Candriam SCA sold out of ViewRay, Inc. (VRAY) in Q2 2023, closing a stake of 1,812,970 shares — an estimated $5.77M sold.

Candriam SCA first reported a position in VRAY in Q4 2018 and held it in 18 quarters. The position peaked at $10.2M in Q4 2021. 124 funds tracked by Wall St. Rank hold VRAY as of Q2 2023.

  • Candriam SCA reported no remaining ViewRay, Inc. position as of Q2 2023 after selling out during the quarter.
  • Candriam SCA sold 1,812,970 ViewRay, Inc. shares in Q2 2023, an estimated $5.77M.
  • Candriam SCA first reported a position in ViewRay, Inc. in Q4 2018 and held it in 18 quarters.
  • Candriam SCA's ViewRay, Inc. position peaked at $10.2M in Q4 2021.
  • 124 funds tracked by Wall St. Rank held ViewRay, Inc. as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.